Company Filing History:
Years Active: 2002
Title: Baruch Levy - Innovator in Prostate Treatment
Introduction
Baruch Levy is a notable inventor based in Ramat Gan, Israel. He has made significant contributions to the field of medical technology, particularly in the treatment of benign prostatic hyperplasia (BPH). His innovative approach has led to the development of a unique patent that addresses prostatic obstruction.
Latest Patents
Baruch Levy holds a patent for the "Transurethral Volume Reduction of the Prostate" (TUVOR). This process is designed to reduce or relieve prostatic obstruction through a series of carefully structured steps. The TUVOR process includes transurethral incision, de-bulking and intra-prostatic volume reduction, and intra-prostatic void exclusion. Additionally, it involves space filling with adhesive and/or therapeutic polymeric materials, which may include bioactive agents and mechanical means for closure. The final steps consist of endourethral compression and prostatic mass remolding, culminating in the application of an endourethral polymer liner layer. This liner, made from biodegradable polymers, supports the urethra and peri-urethral tissue during healing, potentially eliminating the need for post-procedure catheter drainage. The TUVOR process is designed to allow outpatient treatment under local anesthesia for BPH.
Career Highlights
Baruch Levy is associated with Harmonia Medical Technologies, Inc., where he continues to innovate in the medical field. His work has been instrumental in advancing treatment options for patients suffering from prostate-related issues.
Collaborations
Throughout his career, Baruch has collaborated with esteemed colleagues such as Marvin J. Slepian and Daniel Yachia. These partnerships have contributed to the development and refinement of his innovative medical processes.
Conclusion
Baruch Levy's contributions to the field of medical technology, particularly through his TUVOR patent, highlight his commitment to improving patient care. His innovative approaches continue to pave the way for advancements in the treatment of prostatic obstruction.